Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

EBO.NZ

BUY

EBOS Group Limited · Healthcare · Australia · $2.4B · Avg Vol: $3M/d

70
StockRank
Q
57
V
64
M
37
P/E (TTM)
16.0x
ROE
9.0%
D/E
0.7x
Dividend %
9.0%
Loading...
PRICE (1M)-4.0%
11.1811.5111.8312.1512.47May 8May 29Jun 19
SMA 50SMA 200
Close
$11.96
RSI (14)
59.4
52W High
$23.41
From 52W High
0.5%

SCORE BREAKDOWN

Quality
57
ROIC
8.4%68.3
ROE
9.0%69.5
GP/Assets
37.4%76.3
Op. Margin
2.8%50.3
FCF/Assets
1.2%54.8
Piotroski
83.4
Int. Cover
4.4x53.0
D/E Ratio
0.68x24.2
Current Ratio
1.24x16.8
Value
64
P/E (TTM)
16.0x69.3
EV/EBITDA
11.1x38.9
P/FCF
62.9x30.8
P/B
1.0x78.7
P/S
0.1x98.7
Div Yield
9.0%98.6
Momentum
37
52W High %
51%25.1
RS 6M
-24%51.1
SMA 50/200
0.84x19.0
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
+23%35.9
Q Growth
13%55.8

FUNDAMENTALS

Market Cap
$2.4B
P/E (Forward)
13.0x
Gross Margin
13.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of EBO.NZ are excluded.

TickerCompanyMkt CapStockRankSignal
EBO.NZEBOS Group Limited(you)$2.4B70BUY
SIG.AXSigma Healthcare Limited$24.4B44HOLD
PGC.AXParagon Care Limited$178M25SELL
MYX.AXMayne Pharma Group Limited$140M18STRONG SELL
REG.AXRegis Healthcare Limited$1.4B61HOLD
ANN.AXAnsell Limited$2.8B87STRONG BUY
RHC.AXRamsay Health Care Limited$6.1B75BUY
AVRAnteris Technologies Global Corp.$854M57HOLD
4DX.AX4DMedical Limited$1.7B43HOLD
SHL.AXSonic Healthcare Limited$6.9B84STRONG BUY

Peer medians: ROE -29.2% · P/E 31.0x · Gross margin 54.2%

EBOS Group Limited (EBO.NZ) — Stock Score Summary

EBOS Group Limited (EBO.NZ) has a MoatMap StockRank of 70/100 based on Quality (57/100), Value (64/100), and Momentum (37/100) factor scores. The current signal is BUY.

Key Financial Metrics

Price$11.96
Market Cap$2.4B
P/E (TTM)15.98
P/E (Forward)12.99
Price/Book1.00
Return on Equity9.0%
Return on Invested Capital8.4%
Debt/Equity68.26
Gross Margin13.1%
Operating Margin2.8%
Revenue Growth13.0%
Dividend Yield9.0%
Free Cash Flow$38M

EBOS Group Limited operates in the Medical Distribution industry, part of the Healthcare sector (Australia).

Frequently Asked Questions

What is EBOS Group Limited’s (EBO.NZ) StockRank?
MoatMap’s StockRank for EBOS Group Limited (EBO.NZ) is 70/100, with a Buy signal. It is a composite of Quality (57), Value (64), and Momentum (37) factor ranks across MoatMap’s 20,000+ stock universe.
Does EBOS Group Limited have an economic moat?
EBOS Group Limited (EBO.NZ) has a Quality factor score of 57/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is EBOS Group Limited a buy, hold, or sell?
MoatMap’s current signal for EBOS Group Limited (EBO.NZ) is Buy, based on a StockRank of 70/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is EBOS Group Limited in?
EBOS Group Limited (EBO.NZ) operates in the Healthcare sector, specifically the Medical Distribution industry (Australia).